Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
"Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study." 2025
Example: models of pelvic inflammatory disease show reduced lesion size and inflammatory infiltrate after T4 treatment
MW ~340 Da)
BPC-157s angiogenic response has been described as more potent and consistent than standard angiogenic growth factors in comparative studies, and critically it functions without requiring special delivery systems or carriers, a significant limitation of most conventional growth factors
US$ 23.40
US$ 29.22
US$ 29.54
US$ 27.11
US$ 28.18
US$ 21.10
US$ 26.76
US$ 22.81
US$ 28.07
US$ 23.94
US$ 25.68
